Cleared Traditional

K970695 - ACS:180 BR (AUTOMATED CHEMILUMINESCENCE SYSTEM FOR THE QUANTITATION OF CANCER ANTIGEN 27.29)
(FDA 510(k) Clearance)

Aug 1997
Decision
164d
Days
Class 2
Risk

K970695 is an FDA 510(k) clearance for the ACS:180 BR (AUTOMATED CHEMILUMINESCENCE SYSTEM FOR THE QUANTITATION OF CANCER ANTIGEN 27.29). This device is classified as a System, Test, Immunological, Antigen, Tumor (Class II - Special Controls, product code MOI).

Submitted by Chiron Diagnostics Corp. (Alameda, US). The FDA issued a Cleared decision on August 8, 1997, 164 days after receiving the submission on February 25, 1997.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K970695 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 25, 1997
Decision Date August 08, 1997
Days to Decision 164 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MOI — System, Test, Immunological, Antigen, Tumor
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — MOI System, Test, Immunological, Antigen, Tumor

All 27
Access BR Monitor
K240403 · Beckman Coulter, Inc. · May 2024
IMMULITE? 2000 BR-MA
K233946 · Siemens Healthcare Diagnostics Products, Ltd. · Mar 2024
Lumipulse G CA15-3
K192524 · Fujirebio Diagnostics,Inc. · Sep 2020
ADVIA Centaur BR
K193489 · Siemens Healthcare Diagnostics, Inc. · Feb 2020
ADVIA Centaur CA 15-3 assay
K192777 · Siemens Healthcare Diagnostics, Inc. · Nov 2019
Elecsys CA 15-3 II
K181492 · Roche Diagnostics · Jun 2018